Accessibility Menu
NuCana Plc logo

NuCana Plc

(NASDAQ) NCNA

Current Price$1.69
Market Cap$7.12M
Since IPO (2017)-100%
5 Year-100%
1 Year-99%
1 Month-15%

NuCana Plc Financials at a Glance

Market Cap

$7.12M

Revenue (TTM)

$0.00

Net Income (TTM)

$27.52M

EPS (TTM)

$-163.35

P/E Ratio

-0.01

Dividend

$0.00

Beta (Volatility)

1.07 (Average)

Price

$1.69

Volume

569

Open

$1.67

Previous Close

$1.71

Daily Range

$1.63 - $1.75

52-Week Range

$1.63 - $268.00

NCNA News

No articles available.

NCNA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NuCana Plc

Industry

Biotechnology

Employees

22

CEO

Hugh Stephen Griffith, MBA

Headquarters

Edinburgh, EH12 9DT, GB

NCNA Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-179%

Return on Capital

-63%

Return on Assets

-85%

Earnings Yield

-100.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.12M

Shares Outstanding

4.16M

Volume

569

Short Interest

0.00%

Avg. Volume

63.17K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$22.81M

EBITDA

$22.48M

Operating Cash Flow

$19.12M

Capital Expenditure

$293.00K

Free Cash Flow

$19.41M

Cash & ST Invst.

$6.75M

Total Debt

$190.00K

NuCana Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$7.12M

N/A

Market Cap/Employee

$355.84K

N/A

Employees

20

N/A

Net Income

$281.00K

+93.8%

EBITDA

$3.50M

+29.4%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$25.11M

+125.6%

Accounts Receivable

$4.59M

-17.0%

Inventory

$0.00

N/A

Long Term Debt

$60.00K

-55.9%

Short Term Debt

$76.00K

-10.6%

Return on Assets

-85.16%

N/A

Return on Invested Capital

-62.68%

N/A

Free Cash Flow

$1.23M

+126.4%

Operating Cash Flow

$1.28M

+127.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CLGNCollPlant Biotechnologies Ltd.
$0.61+0.00%
MTVAMetaVia Inc.
$1.48+0.00%
CASICASI Pharmaceuticals, Inc.
$0.15+3.08%
CLSDClearside Biomedical, Inc.
$0.41+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$45.69-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.97-0.06%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$75.91+0.01%
IBITiShares Bitcoin Trust
$39.82-0.01%

Questions About NCNA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.